The 2020 WHO classification of tumors of bone: an updated review
JH Choi, JY Ro - Advances in anatomic pathology, 2021 - journals.lww.com
Bone tumors are a rare and heterogeneous group of neoplasms that occur in the bone. The
diversity and considerable morphologic overlap of bone tumors with other mesenchymal …
diversity and considerable morphologic overlap of bone tumors with other mesenchymal …
Cartilage tumours and bone development: molecular pathology and possible therapeutic targets
As a group, cartilage tumours are the most common primary bone lesions. They range from
benign lesions, such as enchondromas and osteochondromas, to malignant …
benign lesions, such as enchondromas and osteochondromas, to malignant …
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
PCW Hogendoorn, N Athanasou, S Bielack… - Annals of …, 2010 - annalsofoncology.org
background A general overview of the histological types of primary malignant bone tumour
according to the World Health Organization (WHO) classification is given in Table 1. Several …
according to the World Health Organization (WHO) classification is given in Table 1. Several …
Novel therapeutic approaches in chondrosarcoma
G Polychronidou, V Karavasilis, SM Pollack… - Future …, 2017 - Taylor & Francis
Chondrosarcoma is a malignant tumor of bones, characterized by the production of cartilage
matrix. Due to lack of effective treatment for advanced disease, the clinical management of …
matrix. Due to lack of effective treatment for advanced disease, the clinical management of …
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor
BACKGROUND Alveolar soft part sarcoma (ASPS), chondrosarcoma (CS), chordoma,
epithelioid sarcoma, and solitary fibrous tumor (SFT) are malignant tumors that are relatively …
epithelioid sarcoma, and solitary fibrous tumor (SFT) are malignant tumors that are relatively …
Advances in sarcoma diagnostics and treatment
AR Dancsok, K Asleh-Aburaya, TO Nielsen - Oncotarget, 2016 - pmc.ncbi.nlm.nih.gov
The heterogeneity of sarcomas with regard to molecular genesis, histology, clinical
characteristics, and response to treatment makes management of these rare yet diverse …
characteristics, and response to treatment makes management of these rare yet diverse …
Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-up
Background and purpose There have been few long-term studies on the outcome of
chondrosarcoma and the findings regarding prognostic factors are controversial. We …
chondrosarcoma and the findings regarding prognostic factors are controversial. We …
Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets
E Nazeri, MG Savadkoohi, K Majidzadeh-A… - Critical reviews in …, 2018 - Elsevier
Sarcomas are known as a heterogeneous class of cancers arisen in the connective tissues
and demonstrated various histological subtypes including both soft tissue and bone origin …
and demonstrated various histological subtypes including both soft tissue and bone origin …
SARC009: phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma
SM Schuetze, JK Wathen, DR Lucas, E Choy… - Cancer, 2016 - Wiley Online Library
BACKGROUND Dasatinib exhibited activity in preclinical models of sarcoma. The Sarcoma
Alliance for Research through Collaboration (SARC) conducted a multicenter, phase 2 trial …
Alliance for Research through Collaboration (SARC) conducted a multicenter, phase 2 trial …
Chondrosarcoma: a rare misfortune in aging human cartilage? The role of stem and progenitor cells in proliferation, malignant degeneration and therapeutic …
Unlike other malignant bone tumors including osteosarcomas and Ewing sarcomas with a
peak incidence in adolescents and young adults, conventional and dedifferentiated …
peak incidence in adolescents and young adults, conventional and dedifferentiated …